Skip to main content
Clinical Trials/DRKS00029137
DRKS00029137
Completed
未知

Visual function, optical disturbance, spectacle independence and patient satisfaction after implantation of trifocal intraocular lens (Acrysof IQ PanOptix) in cataract patients: unilateral versus bilateral implantation.

MVZ RHR Augenärzte GmbH Düsseldorf0 sites72 target enrollmentJuly 5, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
H26.9
Sponsor
MVZ RHR Augenärzte GmbH Düsseldorf
Enrollment
72
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2022
End Date
October 25, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
MVZ RHR Augenärzte GmbH Düsseldorf

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with cataract in both eyes and with a medical indication of a cataract extraction with an implantation of an artificial lens. All the patients have voluntarily and independent from the study decided for a unilateral or bilateral implantation of a trifocal Acrysof IQ PanOptix lens, after a medical enlightenment talk with the treated ophthalmologist. Only capable of consent adults will be included in the study.
  • 2\. Age 50\-81\.
  • 3\. No other eye disease.
  • 4\. No refractive operation in the patient history.
  • 5\. No secondary cataract or already treated secondary cataract with YAG\-Laser Kapsulotomy by the time of the evaluation 3 months after the second operation.

Exclusion Criteria

  • 1\. Missing patient consent
  • 2\. Presence of other eye diseases
  • 3\. Postoperative complications that affect the visual aquity
  • 4\. Necessity for a re\-operation
  • 5\. No appearance for the postoperativ evaluation (follow\-up).

Outcomes

Primary Outcomes

Not specified

Similar Trials